Thursday, 31 March 2022

Common coronavirus infections don’t generate effective antibodies against SARS-CoV-2

Common coronavirus infections don’t generate effective antibodies against SARS-CoV-2
Common coronavirus infections don’t generate effective antibodies against SARS-CoV-2

Although SARS-CoV-2 has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease. Now, researchers reporting in ACS Infectious Diseases have shown that infections with two different HCoVs don’t generate antibodies that effectively cross-react with SARS-CoV-2. So, prior infection with HCoVs is unlikely to protect against COVID-19 or worsen a SARS-CoV-2 infection through antibody-dependent enhancement (ADE), the researchers say.

admin Thu, 03/31/2022 - 17:04

source https://www.pharmatutor.org/pharma-news/2022/common-coronavirus-infections-don-generate-effective-antibodies-against-sars-cov-2

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...